Thus, Carm1-deficient mice are resistant to MLL-AF9-induced acute myeloid leukemia (Greenblatt et al., 2016; Greenblatt et al., 2018), probably because a critical target protein cannot be methylated by the enzyme. This evidence concerns the gene CARM1 and acute myeloid leukemia.